MD1138C2 - Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity - Google Patents

Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity

Info

Publication number
MD1138C2
MD1138C2 MD97-0050A MD970050A MD1138C2 MD 1138 C2 MD1138 C2 MD 1138C2 MD 970050 A MD970050 A MD 970050A MD 1138 C2 MD1138 C2 MD 1138C2
Authority
MD
Moldova
Prior art keywords
isopropylphosphite
possessing
isopropylisothiuronium
hypertensive activity
isothiourea derivative
Prior art date
Application number
MD97-0050A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD1138B1 (en
Inventor
Виктор ГИКАВЫЙ
Victor Darciuc
Lev Mizrah
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MD97-0050A priority Critical patent/MD1138C2/en
Publication of MD1138B1 publication Critical patent/MD1138B1/en
Publication of MD1138C2 publication Critical patent/MD1138C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, particularly, to remedies necessary for arterial tension correction at the acute arterial hypotension state.Summary of the invention consists in the fact that as a material possessing the hypertensive activity there is used isothiourea derivative, namely, isopropylphosphite-S-isopropyl isothiuronium.
MD97-0050A 1997-02-17 1997-02-17 Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity MD1138C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0050A MD1138C2 (en) 1997-02-17 1997-02-17 Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0050A MD1138C2 (en) 1997-02-17 1997-02-17 Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity

Publications (2)

Publication Number Publication Date
MD1138B1 MD1138B1 (en) 1999-01-31
MD1138C2 true MD1138C2 (en) 1999-07-31

Family

ID=19738967

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0050A MD1138C2 (en) 1997-02-17 1997-02-17 Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity

Country Status (1)

Country Link
MD (1) MD1138C2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies
MD2228G2 (en) * 2003-01-21 2004-02-29 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD675Z (en) * 2013-03-15 2014-04-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prevention of pathological reflexes during surgical manipulations

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1315505B1 (en) * 2000-09-05 2007-10-17 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions for headache, migraine, nausea and emesis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (en) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ "Isoturon" means with antihypotensive activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (en) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ "Isoturon" means with antihypotensive activity

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies
MD2228G2 (en) * 2003-01-21 2004-02-29 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD675Z (en) * 2013-03-15 2014-04-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prevention of pathological reflexes during surgical manipulations

Also Published As

Publication number Publication date
MD1138B1 (en) 1999-01-31

Similar Documents

Publication Publication Date Title
MX9601360A (en) Synergistic stabilizing mixture.
NZ331440A (en) Ostomy device tail clip having interengaging parts notched to facilitate trimming to a desired length
DE3574014D1 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
BG102804A (en) New application of n-(phosphonomethyl)glycine and its derivatives
AU3192495A (en) N,n-disubstituted amic acid derivative
DE69823319D1 (en) Insoluble insulin compositions for regulation of blood glucose
LT96025A (en) Therapeutic peptide derivatives
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
BG102644A (en) IMPROVED CONCENTRATED INJECTION AND INFUSION SOLUTIONS FOR INTRAVASAL ADMINISTRATION
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
IN2012DE00109A (en)
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti
TW324662B (en) Benzamide-containing pharmaceutical composition
US5690869C1 (en) Use of a polymer material on the basis of modified hydrocolloids as covering material
WO1996008228A3 (en) Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
MX9707683A (en) Combination compositions containing benazepril or benazeprilat and valsartan.
ATE258797T1 (en) USE OF AMIFOSTINE
MD1138B1 (en) Isopropylphosphite-S-isopropylisothiuronium - isothiourea derivative - possessing the hypertensive activity
AU2895397A (en) Novel substance library and supramolecular complexes prepared therewith
WO2000061551A3 (en) Pyrimidine-2-one derivatives as integrin receptor ligands
NO985462D0 (en) Carbohydrate derivatives and solid phase synthesis thereof
ATE242224T1 (en) FUNGICIDAL AZA-HETEROCYCLOALKENES
WO2001010422A3 (en) Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinframmatory agents
IS5231A (en) Tissue factor affecting blood vessels